Apollo Medical Holdings Investor Presentation Deck
ApolloMed at-a-glance
Apollo Medical Holdings ("ApolloMed") is a
leading physician-centric, technology-
powered, risk-bearing healthcare company
Our end-to-end technology solutions enable
providers to succeed in value-based care
arrangements where they "quarterback"
patient care to deliver better outcomes
We manage over 1.2M lives through a
network of 14 IPAs and 9,800+ contracted
physicians, working with 20+ payer partners
We have a 25+ year track record of
profitable growth in our core geographic
areas and a comprehensive strategy to grow
nationally
1.2M+
Managed lives
9,800+
Contracted physicians
66%(1)
Fewer hospital admits per
1,000 vs. benchmark
$186M(2,3)
TTM adj. EBITDA
20+
Payer partners
71% (¹1)
Fewer ER visits per
1,000 vs. benchmark
$955M(3)
TTM revenue
10-15%
Long-term EBITDA margin
Source: CMS, Chronic Conditions Data Warehouse (CCW), competitors' IR, and internal figures. Internal figures for capitated MA patients
Note: Information as of 12/31/2021 unless otherwise noted; competitor and national information provided is 2019 data unless otherwise noted
(1) Internal Medicare patient data from consolidated IPAs from Jan 2021 - Sept 2021; (2) See "Reconciliation of Net Income to EBITDA and Adjusted EBITDA" and "Use of Non-GAAP Financial Measures" slides for more
information: (3) TTM as of 6/30/2022
apollomed
5View entire presentation